| Gene Name |
Pubmed ID |
Classification |
Sample Location |
Remark |
| BCL2 | 17242701 | Upregulation | Gynecological Cancer Centre of St bartholomew's Hospital and the Department of Obsterics and Gynecology of the Clinical Centre of Serbia. | It is commonly upregulated in LN micrometastases in cervical cancer. BCL2 is an antiapototic gene and increased expression is associated with poor responses to systematic treatment of cancer. |
| BCL2 | 17306351 | Overexpression | - | It's overexpressed in cervical squamous cell carcinoma. It appears to be associated with the development, aggressiveness and progression of cervical cancer. |
| BCL2 | 12657131 | - | - | BCL2 expressed in small cell carcinoma of the cervix |
| BCL2 | 17632454 | Overexpression | - | BCL2 expression has been reported to be increased in intensity and proportion in CIN specimen. |
| BCL2 | 10999751 | - | - | BCL2 expression is detected in 14.3% in noninvasive squamous cell carcinoma and 65.2% of invasive squamous cell carcinoma (P<0.003). |
| BCL2 | 17464868 | Upregulation | - | BCL2 expression is positively related to the degree of metastasis; cases with lymph node metastasis showed significantly higher BCL2 expression compared with those without metastasis. |
| BCL2 | 11198267 | - | Department of Obstertics and Gynecology of the Catholic University, Rome | A significant association of bcl2 levels with age (p<0.021) and menopausal status (p<0.041) in cervical cancer patients as well as in control patients. |